查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1970693

客製化基因合成​​服务市场－全球产业规模、份额、趋势、机会、预测：按类型、应用、地区和竞争格局划分，2021-2031年

Custom Gene Synthesis Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球客製化基因合成​​服务市场预计将从 2025 年的 15.9 亿美元成长到 2031 年的 26.1 亿美元，复合年增长率为 8.61%。

该产业的核心在于双股DNA分子的新型合成，因此能够产生无需天然模板的精确基因序列。这项技术是製药、农业和学术界基因工程的基础。推动该行业发展的主要动力是生物製药的快速进步以及个人化医疗和疫苗研发对合成DNA的迫切需求。正如美国基因与细胞治疗学会所指出的，到2024年，全球在研基因、细胞和RNA疗法将超过4000种，凸显了该产业对高品质合成遗传材料的巨大需求。

市场概览
预测期 2027-2031
市场规模：2025年 15.9亿美元
市场规模：2031年 26.1亿美元
复合年增长率：2026-2031年 8.61%
成长最快的细分市场 商业
最大的市场 北美洲

儘管市场规模不断扩大，但在合成长或复杂DNA序列方面仍面临许多挑战。使用标准化学方法生产重复结构和高GC含量序列会导致产量降低、错误率升高，从而增加成本并延误生产。这些技术限制阻碍了满足日益增长的工业需求所需的规模化生产，并且随着研究人员越来越依赖复杂、无错的基因构建体进行先进的治疗应用，这些限制可能会限制市场的整体成长。

市场驱动因素

基因和细胞疗法研发的快速发展是全球客製化基因合成​​服务市场的主要驱动力。随着这些先进治疗方法从早期研究阶段迈向商业化阶段，对高品质、符合GMP规范的合成DNA的需求激增，这些DNA是生产质体、病毒载体和引导RNA所必需的。治疗创新领域的快速成长促使人们继续依赖能够提供大规模、精准基因建构的合成供应商，以确保患者照护所需材料的供应。监管方面的进展进一步强化了这一趋势。美国食品药物管理局（FDA）在2023年核准了创纪录的七种新的细胞和基因疗法，显示研发管线日趋成熟，市场对可靠合成组成的需求也不断增长。

同时，自动化和DNA合成平台的技术突破正在克服传统亚磷酰胺化学的局限性，并提升其市场价值。硅基自动化和酵素合成等新技术能够快速产生更长、更精确的序列，直接满足生物药物研发的需求。这些创新吸引了大量投资以扩大产能；例如，Elegen公司于2024年5月完成B轮资金筹措，筹集3,500万美元，用于提升其无细胞DNA生产能力。这种技术整合也带来了财务上的成功，Twist Biosciences公司于2024年11月宣布，其2024财年合成生物学业务的收入为1.235亿美元。

市场挑战

合成长而复杂的DNA序列的难度是限制全球客製化基因合成​​服务市场扩充性的主要技术障碍。製造商难以生产具有复杂重复结构和高GC含量的序列，这通常会导致产量降低和错误率升高。这些技术限制迫使供应商承担高昂的生产成本和漫长的交货週期以确保准确性，最终损害了营运效率。因此，无法快速可靠地交付这些复杂的结构会延误供应链，导致无法充分满足学术机构和製药公司等客户的大量需求，这些客户需要特定的材料来完成高度敏感的计划。

这种运作瓶颈导致治疗研究的加速发展与合成DNA的供给能力之间存在差距，严重阻碍了市场成长。该行业在高效扩大复杂序列生产规模方面面临的挑战，限制了其支持那些依赖及时材料供应的、资金充足的研发倡议的能力。根据SynBioBeta预测，到2024年，合成生物学领域的创投将达到122亿美元。儘管如此巨大的资金流入显示工业界对遗传材料的需求旺盛，但有效合成复杂序列方面持续存在的困难，阻碍了市场充分发挥与这项投资相匹配的成长潜力。

市场趋势

人工智慧 (AI) 正透过序列增强技术优化合成生物学的设计阶段，从根本上改变市场格局。人工智慧演算法的日益普及，使得在物理合成之前即可预测结构稳定性并优化密码子利用率，从而有效降低并加速了候选药物设计、建造和测试週期的失败率。这种向计算设计的转变显着推动了对用于演算法模型物理检验的合成构建体的需求。 2024 年 4 月，Xaira Therapeutics 宣布已获得 10 亿美元的资金筹措，用于推动人工智慧驱动的药物发现。这项巨额投资凸显了业界对高通量基因合成技术的日益依赖，以检验人工智慧产生的蛋白质设计。

同时，DNA资料储存技术的兴起正将市场范围拓展到传统生命科学领域之外。随着全球数位资料产生量超过传统储存容量，合成DNA作为一种高密度、耐用的长期储存媒体正备受关注。这个应用领域正从理论研究转向商业性化，为合成服务供应商将数位资料编码到基因序列中开闢了新的途径。例如，2024年1月，BioMemory公司发布了全球首款商用DNA储存产品（1千位元组容量），展示了该技术在资料归檔方面的实用性和早期商业化前景。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球客製化基因合成​​服务市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（小于 1000 bp、1001-3000 bp、3001-5000 bp、5000 bp 或以上）
    • 依应用领域（商业用途、学术研究用途）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美客製化基因合成​​服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲客製化基因合成​​服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区客製化基因合成​​服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲客製化基因合成​​服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲客製化基因合成​​服务市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球客製化基因合成​​服务市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19087

The Global Custom Gene Synthesis Service Market is projected to expand from USD 1.59 Billion in 2025 to USD 2.61 Billion by 2031, reflecting a compound annual growth rate of 8.61%. This industry centers on the de novo creation of double-stranded DNA molecules, allowing for the generation of precise genetic sequences independent of natural templates, which is fundamental to genetic engineering in pharmaceuticals, agriculture, and academia. Growth is primarily fueled by the rapid advancement of biologics and the urgent demand for synthetic DNA in personalized medicine and vaccine development. As noted by the American Society of Gene & Cell Therapy, the global pipeline contained over 4,000 gene, cell, and RNA therapies in 2024, highlighting the immense industrial requirement for high-grade synthetic genetic materials.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.59 Billion
Market Size 2031USD 2.61 Billion
CAGR 2026-20318.61%
Fastest Growing SegmentCommercial
Largest MarketNorth America

Despite this expansion, the market faces a substantial hurdle in synthesizing long or complex DNA sequences. Producing sequences with repetitive structures or high GC content via standard chemical methods often leads to lower yields and higher error rates, resulting in increased costs and slower production times. This technical limitation hampers the scalability needed to meet growing industrial demands, potentially restricting broader market growth as researchers increasingly depend on intricate, error-free genetic constructs for sophisticated therapeutic applications.

Market Driver

The rapid progression of gene and cell therapy development serves as a major engine for the Global Custom Gene Synthesis Service Market. As these advanced treatments move from early research phases to commercial availability, there is an intensifying need for high-quality, GMP-grade synthetic DNA essential for manufacturing plasmids, viral vectors, and guide RNAs. This boom in therapeutic innovation fosters a continuous reliance on synthesis vendors to provide precise genetic constructs at scale, ensuring the supply of vital materials for patient care. This trend is reinforced by regulatory achievements; the U.S. Food and Drug Administration (FDA) approved a record seven new cell and gene therapies in 2023, signaling a maturing pipeline and a widening market necessity for dependable synthetic components.

Simultaneously, technological breakthroughs in automation and DNA synthesis platforms are boosting market value by resolving the constraints of conventional phosphoramidite chemistry. Newer techniques, such as silicon-based automation and enzymatic synthesis, allow for the fast generation of longer, high-fidelity sequences, directly meeting the needs of biologics discovery. These innovations are drawing significant investment to expand production capacities; for instance, Elegen raised $35 million in Series B funding in May 2024 to enhance its cell-free DNA manufacturing. This technological integration is driving financial success, as evidenced by Twist Bioscience, which reported in November 2024 that its synthetic biology revenue had increased to $123.5 million for the fiscal year 2024.

Market Challenge

The difficulty of synthesizing long and complex DNA sequences creates a major technical obstacle that limits the scalability of the global custom gene synthesis service market. Manufacturers struggle to produce sequences with intricate repetitive structures or high GC content, issues that frequently lead to diminished yields and elevated error rates. These technical constraints force providers to incur higher production costs and face longer turnaround times to guarantee accuracy, ultimately impairing operational efficiency. As a result, the inability to deliver these complex constructs rapidly and reliably slows the supply chain, hindering vendors from fully meeting the high-volume needs of academic and pharmaceutical clients requiring specific materials for sensitive projects.

This operational bottleneck severely impedes market growth by causing a disconnect between the accelerating speed of therapeutic research and the availability of synthetic DNA. The industry's struggle to efficiently scale the production of complex sequences restricts its ability to support well-financed development initiatives that rely on timely material delivery. According to SynBioBeta, venture investment in the synthetic biology sector hit 12.2 billion dollars in 2024. While this massive capital inflow indicates strong industrial demand for genetic materials, persistent difficulties in effectively synthesizing complex sequences prevent the market from fully realizing its growth potential in proportion to this investment.

Market Trends

Artificial intelligence is fundamentally transforming the market by optimizing the design phase of synthetic biology through sequence enhancement. AI algorithms are increasingly utilized to predict structural stability and optimize codon usage prior to physical synthesis, effectively lowering failure rates and speeding up the design-build-test cycle for therapeutic candidates. This shift toward computational design is driving significant demand for synthetic constructs needed to physically validate algorithmic models. In April 2024, Xaira Therapeutics announced it had secured $1 billion in committed capital to further AI-driven drug discovery, a massive investment that highlights the industry's growing dependence on high-throughput gene synthesis to verify protein designs generated by AI.

In parallel, the rise of DNA data storage is broadening the market's reach beyond traditional life sciences. With global digital data production exceeding conventional storage capabilities, synthetic DNA is gaining traction as a high-density, durable medium for long-term archiving. This application is moving from theoretical research to commercial viability, opening a new avenue for synthesis providers to encode digital data into genetic sequences. For example, in January 2024, Biomemory launched the world's first commercially available DNA storage product with a 1-kilobyte capacity, proving the practical feasibility and initial commercialization of this technology for archival needs.

Key Market Players

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

Report Scope

In this report, the Global Custom Gene Synthesis Service Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Custom Gene Synthesis Service Market, By Type

  • Below 1000 bp
  • 1001 to 3000 bp
  • 3001 to 5000 bp
  • above 5000 bp

Custom Gene Synthesis Service Market, By Application

  • Commercial
  • Academic Research

Custom Gene Synthesis Service Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Custom Gene Synthesis Service Market.

Available Customizations:

Global Custom Gene Synthesis Service Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Custom Gene Synthesis Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Below 1000 bp, 1001 to 3000 bp, 3001 to 5000 bp, above 5000 bp)
    • 5.2.2. By Application (Commercial, Academic Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Custom Gene Synthesis Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Custom Gene Synthesis Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Custom Gene Synthesis Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Custom Gene Synthesis Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Custom Gene Synthesis Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Custom Gene Synthesis Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Custom Gene Synthesis Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Custom Gene Synthesis Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Custom Gene Synthesis Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Custom Gene Synthesis Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Custom Gene Synthesis Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Custom Gene Synthesis Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Custom Gene Synthesis Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Custom Gene Synthesis Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Custom Gene Synthesis Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Custom Gene Synthesis Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Custom Gene Synthesis Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Custom Gene Synthesis Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Custom Gene Synthesis Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Custom Gene Synthesis Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Custom Gene Synthesis Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Custom Gene Synthesis Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Custom Gene Synthesis Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Custom Gene Synthesis Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Custom Gene Synthesis Service Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GenScript Biotech Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Biomatik Corporation
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Integrated DNA Technologies, Inc.
  • 15.5. Synbio Technologies LLC
  • 15.6. Biomol GmbH
  • 15.7. Eurofins Genomics Germany GmbH
  • 15.8. BioCat GmbH
  • 15.9. Azenta US Inc.
  • 15.10. ProMab Biotechnologies, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer